Class Action Filed Against LifeMD Over Alleged Securities Fraud
A class action lawsuit has been filed against LifeMD, Inc. (NASDAQ: LFMD) on behalf of investors who were allegedly harmed by securities fraud between May 7, 2025 and August 5, 2025. The complaint alleges that defendants made false statements and/or concealed material information about LifeMD's competitive position and financial guidance.
The lawsuit, filed by Levi & Korsinsky, LLP, alleges that the defendants were reckless in raising LifeMD's 2025 guidance due to improper accounting of customer acquisition costs. This, it is claimed, led to a material overstatement of LifeMD's competitive position. Investors in LifeMD who were adversely affected during the relevant time frame have until October 25, 2025 to request appointment as lead plaintiff in the case. Joseph E. Levi, Esq. is one of the lead attorneys representing the investors.
The lawsuit seeks to hold LifeMD and its defendants accountable for their alleged actions. It is important for investors to understand their rights and take appropriate action if they believe they have been harmed. For more information about the case or to discuss potential legal options, investors can contact Levi & Korsinsky, LLP.
Read also:
- Orioles' 2025 Turnaround Powered by Late-Season Pitching Acquisitions
- The Cost of Speech is Zero, True Strength Lies in Unity
- Beginning a Food Truck Venture: Crucial Stages to Achieve Profitability
- Aiming to simplify the move towards cleaner automobiles, the newly established ministry plans to take direct action with Pannier-Runacher, Létard, and Vautrin at the helm.
